AAAAAA

   
Results: 1-25 | 26-44
Results: 1-25/44
Strategies for improved antigen delivery into dendritic cells
Authors: Rea, D Johnson, ME Havenga, MJE Melief, CJM Offringa, R
Citation: D. Rea et al., Strategies for improved antigen delivery into dendritic cells, TRENDS MO M, 7(3), 2001, pp. 91-94
An Arabidopsis Minute-like phenotype caused by a semi-dominant mutation ina RIBOSOMAL PROTEIN S5 gene
Authors: Weijers, D Franke-van Dijk, M Vencken, RJ Quint, A Hooykaas, P Offringa, R
Citation: D. Weijers et al., An Arabidopsis Minute-like phenotype caused by a semi-dominant mutation ina RIBOSOMAL PROTEIN S5 gene, DEVELOPMENT, 128(21), 2001, pp. 4289-4299
The PINOID protein kinase regulates organ development in Arabidopsis by enhancing polar auxin transport
Authors: Benjamins, R Quint, A Weijers, D Hooykaas, P Offringa, R
Citation: R. Benjamins et al., The PINOID protein kinase regulates organ development in Arabidopsis by enhancing polar auxin transport, DEVELOPMENT, 128(20), 2001, pp. 4057-4067
The self peptide annexin II (208-223) presented by dendritic cells sensitizes autologous CD4+T lymphocytes to recognize melanoma cells
Authors: Heinzel, S Rea, D Offringa, R Pawelec, G
Citation: S. Heinzel et al., The self peptide annexin II (208-223) presented by dendritic cells sensitizes autologous CD4+T lymphocytes to recognize melanoma cells, CANCER IMMU, 49(12), 2001, pp. 671-678
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens
Authors: van der Burg, SH Kwappenberg, KMC O'Neill, T Brandt, RMP Melief, CJM Hickling, JK Offringa, R
Citation: Sh. Van Der Burg et al., Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens, VACCINE, 19(27), 2001, pp. 3652-3660
Seed development - Early paternal gene activity in Arabidopsis
Authors: Weijers, D Geldner, N Offringa, R Jurgens, G
Citation: D. Weijers et al., Seed development - Early paternal gene activity in Arabidopsis, NATURE, 414(6865), 2001, pp. 709-710
Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors
Authors: Medema, JP de Jong, J Peltenburg, LTC Verdegaal, EME Gorter, A Bres, SA Franken, KLMC Hahne, M Albar, JP Melief, CJM Offringa, R
Citation: Jp. Medema et al., Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors, P NAS US, 98(20), 2001, pp. 11515-11520
Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus tolerance
Authors: den Boer, AT Diehl, L van Mierlo, GJD van der Voort, EIH Fransen, MF Krimpenfort, P Melief, CJM Offringa, R Toes, REM
Citation: At. Den Boer et al., Longevity of antigen presentation and activation status of APC are decisive factors in the balance between CTL immunity versus tolerance, J IMMUNOL, 167(5), 2001, pp. 2522-2528
Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells
Authors: Rea, D Havenga, MJE van den Assem, M Sutmuller, RPM Lemckert, A Hoeben, RC Bout, A Melief, CJM Offringa, R
Citation: D. Rea et al., Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells, J IMMUNOL, 166(8), 2001, pp. 5236-5244
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
Authors: Sutmuller, RPM van Dulvenvoorde, LM van Elsas, A Schumacher, TNM Wildenberg, ME Allison, JP Toes, REM Offringa, R Melief, CJM
Citation: Rpm. Sutmuller et al., Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses, J EXP MED, 194(6), 2001, pp. 823-832
Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: Differential modulation by T helper type 1 and type 2 cells
Authors: Medema, JP Schuurhuis, DH Rea, D van Tongeren, J de Jong, J Bres, SA Laban, S Toes, REM Toebes, M Schumacher, TNM Bladergroen, BA Ossendorp, F Kummer, JA Melief, CJM Offringa, R
Citation: Jp. Medema et al., Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: Differential modulation by T helper type 1 and type 2 cells, J EXP MED, 194(5), 2001, pp. 657-667
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy
Authors: van Elsas, A Sutmuller, RPM Hurwitz, AA Ziskin, J Villasenor, J Medema, JP Overwijk, W Restifo, NP Melief, CJM Offringa, R Allison, JP
Citation: A. Van Elsas et al., Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: Comparison of prophylaxis and therapy, J EXP MED, 194(4), 2001, pp. 481-489
Efficient identification of novel HLA-A0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis
Authors: Kessler, JH Beekman, NJ Bres-Vloemans, SA Verdijk, P van Veelen, PA Kloosterman-Joosten, AM Vissers, DCJ ten Bosch, GJA Kester, MGD Sijts, A Drijfhout, JW Ossendorp, F Offringa, R Melief, CJM
Citation: Jh. Kessler et al., Efficient identification of novel HLA-A0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis, J EXP MED, 193(1), 2001, pp. 73-88
Natural T-HELPER immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: Identification of 3 human leukocyte antigen class II-restricted epitopes
Authors: van der Burg, SH Ressing, ME Kwappenberg, KMC de Jong, A Straathof, K de Jong, J Geluk, A van Meugaarden, KE Franken, KLMC Ottenhoff, THM Fleuren, GJ Kenter, G Melief, CJM Offringa, R
Citation: Sh. Van Der Burg et al., Natural T-HELPER immunity against human papillomavirus type 16 (HPV16) E7-derived peptide epitopes in patients with HPV16-positive cervical lesions: Identification of 3 human leukocyte antigen class II-restricted epitopes, INT J CANC, 91(5), 2001, pp. 612-618
Identification of three non-VNTR MUC1-derived HLA-A0201-restricted T-cellepitopes that induce protective anti-tumor immunity in HLA-A2/K-b-transgenic mice
Authors: Heukamp, LC van der Burg, SH Drijfhout, JW Melief, CJM Taylor-Papadimitriou, J Offringa, R
Citation: Lc. Heukamp et al., Identification of three non-VNTR MUC1-derived HLA-A0201-restricted T-cellepitopes that induce protective anti-tumor immunity in HLA-A2/K-b-transgenic mice, INT J CANC, 91(3), 2001, pp. 385-392
Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer
Authors: van der Burg, SH de Cock, K Menon, AG Franken, KLMC Palmen, M Redeker, A Drijfhout, JW Kuppen, PJK van de Velde, CJH Erdile, L Tollenaar, RAEM Melief, CJM Offringa, R
Citation: Sh. Van Der Burg et al., Long lasting p53-specific T cell memory responses in the absence of anti-p53 antibodies in patients with resected primary colorectal cancer, EUR J IMMUN, 31(1), 2001, pp. 146-155
Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma
Authors: Ressing, ME van Driel, WJ Brandt, RMP Kenter, GG de Jong, JH Bauknecht, T Fleuren, GJ Hoogerhout, P Offringa, R Sette, A Celis, E Grey, H Trimbos, BJ Kast, WM Melief, CJM
Citation: Me. Ressing et al., Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma, J IMMUNOTH, 23(2), 2000, pp. 255-266
Design and evaluation of antigen-specific vaccination strategies against cancer
Authors: Offringa, R van der Burg, SH Ossendorp, F Toes, REM Melief, CJM
Citation: R. Offringa et al., Design and evaluation of antigen-specific vaccination strategies against cancer, CURR OP IM, 12(5), 2000, pp. 576-582
The role of CD40 in peripheral T cell tolerance and immunity
Authors: Diehl, L Den Boer, AT van der Voort, EIH Melief, CJM Offringa, R Toes, REM
Citation: L. Diehl et al., The role of CD40 in peripheral T cell tolerance and immunity, J MOL MED-J, 78(7), 2000, pp. 363-371
Importance of CD4(+) T helper cell responses in tumor immunity
Authors: Ossendorp, F Toes, REM Offringa, R van der Burg, SH Melief, CJM
Citation: F. Ossendorp et al., Importance of CD4(+) T helper cell responses in tumor immunity, IMMUNOL LET, 74(1), 2000, pp. 75-79
Strategies for immunotherapy of cancer
Authors: Melief, CJM Toes, REM Medema, JP Van der Burg, SH Ossendorp, F Offringa, R
Citation: Cjm. Melief et al., Strategies for immunotherapy of cancer, ADV IMMUNOL, 75, 2000, pp. 235-282
Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin
Authors: van Hall, T van Bergen, J van Veelen, PA Kraakman, M Henkamp, LC Koning, F Melief, CJM Ossendorp, F Offringa, R
Citation: T. Van Hall et al., Identification of a novel tumor-specific CTL epitope presented by RMA, EL-4, and MBL-2 lymphomas reveals their common origin, J IMMUNOL, 165(2), 2000, pp. 869-877
Adaptive T cell immunotherapy of human uveal melanoma targeting gp100
Authors: Sutmuller, RPM Schurmans, LRHM van Duivenvoorde, LM Tine, JA van der Voort, EIH Toes, REM Melief, CJM Jager, MJ Offringa, R
Citation: Rpm. Sutmuller et al., Adaptive T cell immunotherapy of human uveal melanoma targeting gp100, J IMMUNOL, 165(12), 2000, pp. 7308-7315
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28
Authors: van Hall, T Sijts, A Camps, M Offringa, R Melief, C Kloetzel, PM Ossendorp, F
Citation: T. Van Hall et al., Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28, J EXP MED, 192(4), 2000, pp. 483-494
Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli
Authors: Schuurhuis, DH Laban, S Toes, REM Ricciardi-Castagnoli, P Kleijmeer, MJ van der Voort, EIH Rea, D Offringa, R Geuze, HJ Melief, CJM Ossendorp, F
Citation: Dh. Schuurhuis et al., Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli, J EXP MED, 192(1), 2000, pp. 145-150
Risultati: 1-25 | 26-44